Sirolimus Prophylaxis for aGVHD in TME SCID

Stopped Preliminary data suggested a better approach available

Conditions

• Severe Combined Immunodeficiency
• Transplacental Maternal Engraftment
• Stem Cell Transplant

Interventions

• DRUG: Sirolimus

Sponsor

University of California, San Francisco